NCT07550868

Brief Summary

Brief Summary This is a multicenter cohort study designed to evaluate and compare the efficacy and safety of different surgical extents of goniotomy (GT) - specifically 120°, 240°, and 360° - in the treatment of Primary Congenital Glaucoma (PCG). The study incorporates both retrospective and prospective patient enrollment. PCG is a rare, severe, and blinding childhood eye disease for which surgery, particularly angle surgery, is the primary treatment. Goniotomy, a minimally invasive glaucoma surgery (MIGS), is increasingly used. However, the optimal extent of the angle incision remains uncertain, with limited and conflicting evidence comparing different ranges. The study plans to enroll a total of 120 PCG patients, dividing them into three groups based on the surgical extent received (120°, 240°, or 360°). Patients will be recruited from participating ophthalmic centers across China. The study does not involve interventional assignment; grouping is based on the actual procedure performed as part of standard care. The primary outcome measure is the qualified surgical success rate post-operatively, defined as intraocular pressure (IOP) ≤21 mmHg (with or without medication), without vision-threatening complications or the need for further glaucoma surgery. IOP will be measured by Goldmann or iCare tonometry. Secondary outcomes include various safety indicators such as intraoperative and postoperative complications, the number of intraocular pressure-lowering medications required, visual acuity, and the need for further surgery. The study aims to generate comparative evidence to inform clinical decision-making, potentially contributing to optimized surgical guidelines for PCG treatment.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
38mo left

Started May 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Jun 2029

First Submitted

Initial submission to the registry

April 12, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 24, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

April 12, 2026

Last Update Submit

April 18, 2026

Conditions

Keywords

Primary congenital glaucomagoniotomySurgery extents

Outcome Measures

Primary Outcomes (2)

  • Qualified surgery success

    The porportion of participants who achieve Intraocular pressure (IOP) ≤ 21 mmHg regardless of topical hypotensive medications, no vision-threatening complications, and no reoperation. The IOP will be measured using Goldmann applanation tonometry or iCare tonometer.

    Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.

  • Complete surgery success

    The porportion of participants who achieve Intraocular pressure (IOP) ≤ 21 mmHg without any topical hypotensive medications, no vision-threatening complications, and no reoperation. The IOP will be measured using Goldmann applanation tonometry or iCare tonometer.

    Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.

Secondary Outcomes (3)

  • Topical hypotensive medications

    Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.

  • Surgery complications

    Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.

  • Reoperation

    Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.

Other Outcomes (2)

  • Visual function

    Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.

  • Economic burden

    Postoperatively Month 12, Month 24, and Month 36.

Study Arms (3)

120° goniotomy

By reviewing the surgery record: For 120°GT, in the case of the nasal quadrant, a clear corneal incision, typically 2.2-3.0 mm wide, was made in the temporal quadrant before the injection of ophthalmic viscoelastic devices into the anterior chamber. Subsequently, the patient's head was rotated 35-40 degrees away from the surgeon, and the surgical microscope was tilted 30-40 degrees downward toward the surgeon to enable maximal visualization of the nasal angle. Then, a viscoelastic was applied to the corneal surface, and the surgical goniolens was gently positioned on the cornea and adjusted to observe the nasal angle. A microhook was inserted into the anterior chamber through a corneal incision. The tip of a microhook was then inserted into the Schlemm's canal and moved to incise its inner wall and trabecular meshwork with 120°GT. After aspiration of the ophthalmic viscoelastic devices, the corneal incision was closed.

240-degree goniotomy

By reviewing the surgery record: For 240°GT, two corneal incisions were made, for example, in the superonasal and superotemporal quadrants or in the temporal and superonasal quadrants. Curved hooks, such as TMH, LAN, were specifically used for the incision in the superonasal position.

360-degree goniotomy

By reviewing the surgery record: For 360°GT, a corneal incision was made in temporal quadrant firstly. Viscoelastics were then injected into the anterior chamber to deepen it. A 23-gauge tangential paracentesis was performed in either the superonasal or inferonasal quadrant to allow microcatheter entry. A microcatheter was then inserted into the anterior chamber. Under direct visualization with a surgical goniolens, a 1-2 mm goniotomy was performed at the nasal angle using a microblade. Microsurgical forceps were then used to grasp the microcatheter within the anterior chamber and guide its distal tip into the SC at the goniotomy incision. The microsurgical forceps were used to advance the catheter through the canal circumferentially. Once the distal tip was retrieved after the catheter had passed 360 degrees, it was externalized through the temporal corneal incision. Next, traction was applied to the proximal aspect of the catheter and complete the surgery.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the outpatient clinics of the glaucoma departments or ophthalmology departments at all participating ophthalmic centers or hospitals. Eligible cases meeting the study criteria will be selected from the medical record systems of these participating centers or hospitals.

You may qualify if:

  • Diagnosis of primary congenital glaucoma (PCG).
  • Underwent goniotomy (GT) of varying extents and grouped by surgical records (120° or 240°or 360°).
  • Either gender; no age limit at surgery.
  • Voluntary participation, signed informed consent, and compliance with scheduled follow-up. For legally incompetent patients, participation shall be decided by their guardians, who shall provide written informed consent and agree to follow-up.
  • Both eyes are included if data are available for both eyes.

You may not qualify if:

  • Concomitant other ocular diseases: including but not limited to diabetic retinopathy, macular degeneration, optic neuropathy, ocular trauma, strabismus, nystagmus, severe dry eye disease, blepharoptosis, or other anterior segment developmental abnormalities.
  • The study eye treated with goniotomy (GT) has a history of prior intraocular surgery or ocular trauma.
  • Concomitant history of severe systemic diseases: including but not limited to asthma, congenital heart disease, Kawasaki disease, nephropathy, rheumatic and immunologic disorders, digestive system diseases, and malignant neoplasms.
  • Women who are pregnant or lactating, or those with an intended pregnancy in the near future.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, China

Location

Related Publications (34)

  • Hu M, Qiao CY, Wang NL. [Research progress in the diagnosis and treatment of childhood glaucoma]. Zhonghua Yan Ke Za Zhi. 2024 May 11;60(5):458-466. doi: 10.3760/cma.j.cn112142-20231202-00266. Chinese.

    PMID: 38706086BACKGROUND
  • Malek I, Sayadi J, Choura R, et al. Outcomes of trabeculotomy for primary congenital glaucoma in a Tunisian population. 2023.

    BACKGROUND
  • Al-Hazmi A, Awad A, Zwaan J, Al-Mesfer SA, Al-Jadaan I, Al-Mohammed A. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol. 2005 Apr;89(4):449-53. doi: 10.1136/bjo.2004.047761.

    PMID: 15774922BACKGROUND
  • Elhilali HM, El Sayed YM, Elhusseiny AM, Gawdat GI. Kahook Dual Blade Ab-interno Trabeculectomy Compared With Conventional Goniotomy in the Treatment of Primary Congenital Glaucoma: 1-Year Results. J Glaucoma. 2021 Jun 1;30(6):526-531. doi: 10.1097/IJG.0000000000001780.

    PMID: 33394855BACKGROUND
  • Mendicino ME, Lynch MG, Drack A, Beck AD, Harbin T, Pollard Z, Vela MA, Lynn MJ. Long-term surgical and visual outcomes in primary congenital glaucoma: 360 degrees trabeculotomy versus goniotomy. J AAPOS. 2000 Aug;4(4):205-10. doi: 10.1067/mpa.2000.106201.

    PMID: 10951295BACKGROUND
  • Elwehidy AS, Bayoumi NHL, Abd Elfattah D, Hagras SM. Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy Versus Rigid Probe Trabeculotomy in Primary Congenital Glaucoma: A 3-Year Randomized Controlled Study. J Glaucoma. 2022 Jan 1;31(1):48-53. doi: 10.1097/IJG.0000000000001944.

    PMID: 34628421BACKGROUND
  • M Elwan SA, A Abdallah RM, Abdelhalim AS. Microcatheter-assisted circumferential trabeculotomy in primary congenital glaucoma. Saudi J Ophthalmol. 2022 Feb 18;35(2):117-121. doi: 10.4103/1319-4534.337864. eCollection 2021 Apr-Jun.

    PMID: 35391820BACKGROUND
  • Neustein RF, Beck AD. Circumferential Trabeculotomy Versus Conventional Angle Surgery: Comparing Long-term Surgical Success and Clinical Outcomes in Children With Primary Congenital Glaucoma. Am J Ophthalmol. 2017 Nov;183:17-24. doi: 10.1016/j.ajo.2017.08.008. Epub 2017 Aug 30.

    PMID: 28860043BACKGROUND
  • Tonset TS, Jakobsen JE, Tveit JH, Jorstad AL, Brevik TB, Sten LB, Drolsum L. Circumferential (360 degrees ) trabeculotomy in primary congenital glaucoma: 19-245 months of follow-up. Acta Ophthalmol. 2021 Dec;99(8):e1449-e1457. doi: 10.1111/aos.14846. Epub 2021 Mar 19.

    PMID: 33742566BACKGROUND
  • Wagdy FM. Ab externo 240-degree trabeculotomy versus trabeculotomy-trabeculectomy in primary congenital glaucoma. Int Ophthalmol. 2020 Oct;40(10):2699-2706. doi: 10.1007/s10792-020-01453-x. Epub 2020 Jun 1.

    PMID: 32488593BACKGROUND
  • El Sayed YM, Gawdat GI. Microcatheter-assisted Trabeculotomy Versus 2-site Trabeculotomy With the Rigid Probe Trabeculotome in Primary Congenital Glaucoma. J Glaucoma. 2018 Apr;27(4):371-376. doi: 10.1097/IJG.0000000000000892.

    PMID: 29394197BACKGROUND
  • Elwehidy AS, Hagras SM, Bayoumi N, AbdelGhafar AE, Badawi AE. Five-year results of viscotrabeculotomy versus conventional trabeculotomy in primary congenital glaucoma: A randomized controlled study. Eur J Ophthalmol. 2021 Mar;31(2):786-795. doi: 10.1177/1120672120922453. Epub 2020 May 26.

    PMID: 32450720BACKGROUND
  • Kessel L, Pedersen KB, Siersma V, Kappelgaard P, Bach-Holm D. Long-term success after trabeculotomy in primary congenital glaucoma - a study with up to 35 years follow-up. Acta Ophthalmol. 2021 Jun;99(4):362-368. doi: 10.1111/aos.14619. Epub 2020 Sep 10.

    PMID: 32914564BACKGROUND
  • Yalvac IS, Satana B, Suveren A, Eksioglu U, Duman S. Success of trabeculotomy in patients with congenital glaucoma operated on within 3 months of birth. Eye (Lond). 2007 Apr;21(4):459-64. doi: 10.1038/sj.eye.6702223. Epub 2006 Jan 6.

    PMID: 16397613BACKGROUND
  • Huang JL, Huang JJ, Zhong YM, Guo XX, Chen XX, Xu XY, Liu X. Surgical Outcomes of Trabeculotomy in Newborns with Primary Congenital Glaucoma. Chin Med J (Engl). 2016 Sep 20;129(18):2178-83. doi: 10.4103/0366-6999.189925.

    PMID: 27625089BACKGROUND
  • El Hefney EM, Atallah EA, Kishk H, Elwehidy AS, Abd Elfattah D. One-year results of double site versus single site rigid probe viscotrabeculotomy in primary congenital glaucoma. Eur J Ophthalmol. 2025 Jul;35(4):1295-1304. doi: 10.1177/11206721241310269. Epub 2025 Jan 29.

    PMID: 39876771BACKGROUND
  • Song Y, Zhu X, Zhang Y, Shu J, Dang G, Zhou W, Sun L, Li F, Lin F, Zhang Y, Liang X, Wang Z, Zhang Y, Zhang Y, Chen W, Zeng L, Tang L, Xie L, Lam DSC, Wang N, Barton K, Weinreb RN, Zhang X; PVP study group. Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study. J Glaucoma. 2023 Jul 1;32(7):563-568. doi: 10.1097/IJG.0000000000002210. Epub 2023 Mar 30.

    PMID: 37054442BACKGROUND
  • Zhang Y, Yu P, Zhang Y, Sugihara K, Zhu X, Zhang Y, Yang X, Li X, Liu Y, Zhang H, Yan X, Zhang H, Lin F, Song Y, Gao X, Yuan H, Tang G, Zhou W, Fan S, Dang G, Tang L, Chen W, Wang N, Park KH, Barton K, Aung T, Lam DSC, Weinreb RN, Xie L, Tanito M, Zeng L, Zhang X; PVP Study Group. Influence of Goniotomy Size on Treatment Safety and Efficacy for Primary Open-Angle Glaucoma: A Multicenter Study. Am J Ophthalmol. 2023 Dec;256:118-125. doi: 10.1016/j.ajo.2023.08.002. Epub 2023 Aug 11.

    PMID: 37573988BACKGROUND
  • Papadopoulos M, Edmunds B, Fenerty C, Khaw PT. Childhood glaucoma surgery in the 21st century. Eye (Lond). 2014 Aug;28(8):931-43. doi: 10.1038/eye.2014.140. Epub 2014 Jun 13.

    PMID: 24924446BACKGROUND
  • Shah M, Bouhenni R, Benmerzouga I. Geographical Variability in CYP1B1 Mutations in Primary Congenital Glaucoma. J Clin Med. 2022 Apr 6;11(7):2048. doi: 10.3390/jcm11072048.

    PMID: 35407656BACKGROUND
  • Tal-Mushinski E, Imtirat A, Kerman T, Yariv I, Dor O, Amitai N, Saadi R, Elsana B, Tsumi E. Ahmed Glaucoma Valve Implantation Versus Trabeculotomy as Initial Intervention for Primary Congenital Glaucoma-Long-Term Follow-Up. J Glaucoma. 2025 Oct 1;34(10):783-788. doi: 10.1097/IJG.0000000000002580. Epub 2025 Apr 25.

    PMID: 40272367BACKGROUND
  • Bayoumi N, Elsayed EN. Secondary intervention after failed initial intervention for primary congenital glaucoma. J Fr Ophtalmol. 2024 Apr;47(4):104077. doi: 10.1016/j.jfo.2024.104077. Epub 2024 Feb 19.

    PMID: 38377874BACKGROUND
  • Lai J, Qiao Y, Tan C, Chen J. Outcomes of gonioscopy-assisted transluminal trabeculotomy in primary congenital glaucoma treatment: a retrospective study. BMC Ophthalmol. 2024 Feb 26;24(1):88. doi: 10.1186/s12886-024-03351-7.

    PMID: 38408950BACKGROUND
  • Kaushik S, Gupta K, Hunashyal S, Sardana M, Thattaruthody F, Pandav SS. Comparison of Bent Ab-Interno Needle Goniectomy and Goniotomy in Primary Congenital Glaucoma: A Randomized Controlled Trial. Ophthalmol Glaucoma. 2025 Jan-Feb;8(1):46-52. doi: 10.1016/j.ogla.2024.08.003. Epub 2024 Aug 22.

    PMID: 39181400BACKGROUND
  • Elwehidy AS, Elhofi AS, Abdelkader AME, GabAllah NM. Two-Year Results of Gonioscopy-Assisted Transluminal Trabeculotomy Versus Ab Externo Visco Circumferential Suture Trabeculotomy in Primary Congenital Glaucoma. J Glaucoma. 2025 Oct 1;34(10):811-818. doi: 10.1097/IJG.0000000000002608. Epub 2025 Jul 10.

    PMID: 40637554BACKGROUND
  • Yeung HH, Walton DS. Goniotomy for juvenile open-angle glaucoma. J Glaucoma. 2010 Jan;19(1):1-4. doi: 10.1097/IJG.0b013e3181a2fa31.

    PMID: 19373104BACKGROUND
  • Lazcano-Gomez G, Garg SJ, Yeu E, Kahook MY. Interim Analysis of STREAMLINE(R) Surgical System Clinical Outcomes in Eyes with Glaucoma. Clin Ophthalmol. 2022 Apr 27;16:1313-1320. doi: 10.2147/OPTH.S358871. eCollection 2022.

    PMID: 35510271BACKGROUND
  • Gupta S, Panigrahi A, R A, Kumar A, Pathak AK, Grover DS, Gupta V. Outcomes of Circumferential Versus Hemi-gonioscopy-Assisted Transluminal Trabeculotomy for Congenital Glaucoma. Am J Ophthalmol. 2025 Mar;271:149-155. doi: 10.1016/j.ajo.2024.10.026. Epub 2024 Nov 7.

    PMID: 39515457BACKGROUND
  • Edo A, Hirooka K, Okumichi H, Yoshinaka A, Kohno S, Kiuchi Y. Surgical outcomes after trabeculotomy for primary congenital glaucoma. Jpn J Ophthalmol. 2025 Jan;69(1):123-130. doi: 10.1007/s10384-024-01152-5. Epub 2025 Jan 24.

    PMID: 39853574BACKGROUND
  • Coviltir V, Marinescu MC, Urse BM, Burcel MG. Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management. Diagnostics (Basel). 2025 Jan 28;15(3):308. doi: 10.3390/diagnostics15030308.

    PMID: 39941238BACKGROUND
  • Chang I, Caprioli J, Ou Y. Surgical Management of Pediatric Glaucoma. Dev Ophthalmol. 2017;59:165-178. doi: 10.1159/000458495. Epub 2017 Apr 25.

    PMID: 28442696BACKGROUND
  • Gagrani M, Garg I, Ghate D. Surgical interventions for primary congenital glaucoma. Cochrane Database Syst Rev. 2020 Aug 25;8(8):CD008213. doi: 10.1002/14651858.CD008213.pub3.

    PMID: 32816311BACKGROUND
  • European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021 Jun;105(Suppl 1):1-169. doi: 10.1136/bjophthalmol-2021-egsguidelines.

    PMID: 34675001BACKGROUND
  • Lee YJ, Ha A, Kang D, Shim SR, Jeoung JW, Park KH, Kim YK. Comparative efficacies of 13 surgical interventions for primary congenital glaucoma in children: a network meta-analysis of randomized clinical trials. Int J Surg. 2023 Apr 1;109(4):953-962. doi: 10.1097/JS9.0000000000000283.

    PMID: 36999777BACKGROUND

MeSH Terms

Conditions

Hydrophthalmos

Condition Hierarchy (Ancestors)

Eye AbnormalitiesEye DiseasesGlaucoma, Open-AngleGlaucomaOcular HypertensionCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Central Study Contacts

Bin Xie, Medical Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Attending Physician

Study Record Dates

First Submitted

April 12, 2026

First Posted

April 24, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

June 1, 2029

Study Completion (Estimated)

June 1, 2029

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations